Spermatogenesis Associated 17 (SPATA17) Peptide
-
- Target See all SPATA17 products
- SPATA17 (Spermatogenesis Associated 17 (SPATA17))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SPATA17 antibody (Catalog #: ARP52643_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SPATA17 (Spermatogenesis Associated 17 (SPATA17))
- Synonyms
- IQCH Peptide, MSRG-11 Peptide, MSRG11 Peptide, RP11-144C20.1 Peptide, 1700065F16Rik Peptide, 4930504I07Rik Peptide, 4930513F16Rik Peptide, spermatogenesis associated 17 Peptide, SPATA17 Peptide, Spata17 Peptide
- Background
-
SPATA17 contains 3 IQ domains. The function of the SPATA17 protein is not known.
Alias Symbols: IQCH, MSRG-11, MSRG11, RP11-144C20.1
Protein Size: 361 - Molecular Weight
- 43 kDa
- Gene ID
- 128153
- NCBI Accession
- NM_138796, NP_620151
- UniProt
- Q96L03
-